ELYXYB (nda212157)- (25MG/ML)

Generic Name	CELECOXIB	Innovator	SCILEX PHARMS
Dosage	25MG/ML
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2036-May-27	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2023-May-05
GAIN Expiry	None	Drug Complexity	No
Indication	ELYXYB is a nonsteroidal anti-inflammatory drug indicated for the acute treatment of migraine with or without aura in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
25MG/ML	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ELYXYB